Manufacturing

Aug 02, 2008
Pharmaceutical Technology
FDA is modernizing adverse-event reporting as part of a revolution in drug-safety assessment.
Aug 02, 2008
Pharmaceutical Technology
Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.
Aug 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Editors' Picks of Pharmaceutical Science & Technology Innovations
Aug 02, 2008
Pharmaceutical Technology
Myth versus Reality: What does Q10 implementation really mean for my company?
Aug 02, 2008
Pharmaceutical Technology
This year's meeting of the Controlled Release Society unveiled a plethora of research insights.
Aug 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Agents report unusual chemistry, abnormal data analysis, and unconventional work practices.
Aug 02, 2008
Pharmaceutical Technology
Patent pressures, changing disease profiles, and higher costs force companies to fight for the top.
Aug 02, 2008
Pharmaceutical Technology
CMOs expand capacity and capabilities in high-potency manufacturing to meet strong demand for cytotoxic and other potent drugs.
Aug 01, 2008
Pharmaceutical Technology
The high-profile case of contaminated heparin from a Chinese supplier has intensified the debate on the effectiveness of FDA's process for inspecting foreign drug-manufacturing facilities. The article examines proposed legislative and regulatory reforms and actions taken by the agency to improve drug-import safety.
Aug 01, 2008
Pharmaceutical Technology
A sponsor company must investigate the manufacturing automation and systems, laboratory automation and systems, information-technology infrastructure, and business applications of each potential contract manufacturing organization.
native1_300x100
lorem ipsum